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Abstract
Introduction:  Guillain-Barré syndrome is an acute demyelinating disorder of the peripheral
nervous system that results from an aberrant immune response directed at peripheral nerves.
Autonomic abnormalities in Guillain-Barré syndrome are usually transient and reversible. We
present a case of Guillain-Barré syndrome requiring a permanent pacemaker in view of persistent
symptomatic bradyarrhythmia.
Case Presentation: An 18-year-old Caucasian female presented with bilateral lower limb
paraesthesias followed by bilateral progressive leg weakness and difficulty in walking. She reported
an episode of an upper respiratory tract infection 3 weeks prior to the onset of her neurological
symptoms. Diagnosis of Guillain-Barré syndrome was considered and a lumbar puncture was
performed. Cerebrospinal fluid revealed albuminocytologic dissociation (increased protein but
normal white blood cell count) suggestive of Guillain-Barré syndrome and hence an intravenous
immunoglobulin G infusion was started. Within 48 hours, she progressed to complete flaccid
quadriparesis with involvement of respiratory muscles requiring mechanical ventilatory support.
Whist in the intensive care unit, she developed multiple episodes of bradycardia and asystole
requiring a temporary pacemaker. In view of the persistent requirement for the temporary
pacemaker for more than 5 days, she received a permanent pacemaker. She returned for follow-
up three months after discharge with an intermittent need for ventricular pacing.
Conclusion: Guillain-Barré syndrome can result in permanent damage to the cardiac conduction
system. Patients with multiple episodes of bradycardia and asystole in the setting of Guillain-Barré
syndrome should be evaluated and considered as potential candidates for permanent pacemaker
implantation.
Introduction
Autonomic neuropathy is an important complication of
Guillain-Barré syndrome (GBS), seen in about 60% cases.
It is common in young adults, presents with more severe
syndromes, and accounts for the mortality in severely
affected individuals. Cardiac autonomic impairment in
GBS includes labile hypertension, orthostatic hypoten-
sion, and a wide range of cardiac arrhythmias including
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sinus tachycardia, serious bradyarrhythmias and asystole.
These manifestations occur primarily from either an
under activity or an excessive activity of the sympathetic or
parasympathetic pathways. We report a case of Guillain-
Barré syndrome requiring permanent pacemaker for
severe bradycardia.
Case Presentation
An 18-year-old Caucasian female presented with bilateral
lower limb paraesthesias followed by increasing leg weak-
ness and difficulty in walking over a period of 2 days. She
reported an episode of an upper respiratory tract infection
3 weeks prior to the onset of her neurological symptoms.
Past, personal and social history was unremarkable. Clin-
ical examination revealed decreased muscle strength in all
extremities associated with hypotonia and areflexia.
A diagnosis of Guillain-Barré Syndrome (GBS) was con-
sidered and a lumbar puncture was performed. Cerebros-
pinal fluid (CSF) revealed albuminocytologic dissociation
(elevated protein with normal white blood cell count in
CSF) suggestive of GBS. She was started on intravenous
immunoglobulin G, but within 48 hours, she progressed
to complete flaccid quadriparesis with involvement of res-
piratory muscles and required mechanical ventilatory
support.
On day 12, a cardiac electrophysiology consultation was
requested for bradycardia and multiple episodes of asys-
tole. These episodes occurred spontaneously, unrelated to
tracheobronchial suctioning, blood drawing or any other
intervention. The longest observed pause was 12 seconds.
Electrolyte profile was normal and oxygenation was satis-
factory. The result of her 12-lead ECG is shown in Figure
1.
In view of the multiple episodes of bradycardia and asys-
tole the decision was made to insert a pacemaker. The
patient initially received a temporary pacemaker. How-
ever, due to an anticipated prolonged clinical course and
the potential for recurrent bradycardia and asystole, an
INSIGNIA Ultra DR dual chamber permanent pacemaker
was implanted after 5 days. The pacemaker was initially
programmed to VVI mode at 40 beats per minute to pre-
vent pacing as much as possible. The pacemaker mode
was switched to DDDR at the time of discharge because of
lack of spontaneous sinus node activity. A paced rhythm
was present 18 days post implant, suggesting occurrence
of intermittent bradycardia.
The patient returned to our office for a routine pacemaker
check 3 months after implantation. The pacemaker check
revealed that she was in paced rhythm for most of the time
A 12-lead ECG showing a 4.2 second pause Figure 1
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in this period. Seventy percent was atrial paced ventricular
sensed rhythm with a set lower rate of 40 beats per min.
Twenty percent was atrial paced ventricular paced rhythm
with a set AV delay of 220 msec. Only for ten percent of
the time was she in atrial sensed ventricular sensed
rhythm. This may indicate prolonged influence on the
autonomic tone even after complete somatic recovery and
likely justifies the need for a permanent pacemaker. As far
as choice of pacemaker mode is concerned, our patient
received a DDDR mode. However, as the 3 month follow
up interrogation showed ventricular pacing of <40%, a
Managed Ventricular Pacing or the AAIsafeR would have
also been a good pacemaker mode option in retrospect.
Discussion
Guillain-Barré Syndrome (GBS) is an acute demyelinating
disorder of the peripheral nervous system that results
from an aberrant immune response directed at peripheral
nerves. Average annual incidence is 1.7 per 100,000 [1]. A
typical GBS patient presents with rapidly ascending sym-
metrical weakness, which may progress to respiratory fail-
ure in 30% of patients [2].
Autonomic dysfunction has been described in GBS and
was noted in as many as 66% of patients in one study [3].
Pathologic studies of the autonomic nervous system in
GBS may demonstrate edema and inflammation of auto-
nomic ganglia and destruction of peripheral ganglion
cells. Chromatolysis, mononuclear cell infiltration, and
nodules of Nageotte can be found within sympathetic
ganglia [4]. Autoantibodies against gangliosides are often
present, such as with anti-GM1 antibodies. Clinical man-
ifestations of dysautonomia can range from seemingly
innocuous profuse perspiration to life threatening
arrhythmias. Sir William Osler described a patient with
GBS who died of "paralysis of the heart" [5]. Autonomic
disturbance most commonly presents as sinus tachycar-
dia, labile hypertension and postural hypotension. How-
ever, sinus bradycardia, asystole, supraventricular
tachycardia, junctional tachycardia and ventricular tachy-
cardia have also been reported. The risk of dysautonomia
is higher in patients with quadriplegia, respiratory failure
or bulbar involvement [6]. Recent studies have indicated
that serious bradyarrhythmias were observed even in less
severely affected patients [7].
Bradyarrhythmias occur in up to 50% of patients with
severe GBS and are due to parasympathetic overactivity
[8]. Episodes of sinus arrest can happen during endotra-
cheal suctioning in patients on ventilators, but can also
happen spontaneously (as in our patient). It results from
a malfunction of afferent baroreceptor reflex. Ropper et al
[9] postulated that afferent baroreflex failure causes labile
blood pressure and release of sympathetic efferents lead-
ing to catecholamine excess. This, in turn, sensitizes left
ventricular stretch receptors and other nociceptors causing
a compensatory reflex bradycardia. Manifestations of
both sympathetic and parasympathetic excess may be
seen in the same patient.
Parasympathetic overactivity may be intermittent, may
cause serious bradyarrhythmias ranging from bradycardia
to asystole, and may account for a significant number of
deaths in GBS patients [4]. It is commonly believed that
marked bradyarrhythmias occur only in severely affected
patients, especially in patients requiring mechanical ven-
tilation [10,11]. However, they have also been reported in
less critically ill patients who do not require mechanical
ventilation [12]. Flachenecker et al have described the eye-
ball pressure test and the 24-hour heart rate power spec-
trum for predicting which patients with GBS will develop
clinically significant bradycardia[12,13].
Review of the literature regarding management of brad-
yarrhythmias associated with GBS shows a lack of uni-
form opinion. The treatment approach has ranged from
the use of isoproterenol and atropine, to insertion of a
temporary or permanent pacemaker [14,15].
Conclusion
Bradyarrhythmias and asystole can be a complicating fac-
tor in GBS with autonomic involvement, requiring careful
monitoring in the ICU setting. Physicians should be vigi-
lant about the presence of these abnormalities in patients
with GBS. Early involvement of an electrophysiology team
in the care of such patients is important. A permanent
pacemaker may be a reasonable intervention if a pro-
tracted recovery is expected.
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